These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20671753)

  • 1. Deal watch: Abbott and Neurocrine to develop promising endometriosis drug.
    Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671753
    [No Abstract]   [Full Text] [Related]  

  • 2. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.
    Ezzati M; Carr BR
    Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elagolix as a Novel Treatment for Endometriosis-Related Pain.
    Fantasia HC
    Nurs Womens Health; 2019 Aug; 23(4):366-369. PubMed ID: 31276630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of elagolix for the treatment of endometriosis.
    Melis GB; Neri M; Corda V; Malune ME; Piras B; Pirarba S; Guerriero S; Orrù M; D'Alterio MN; Angioni S; Paoletti AM
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):581-8. PubMed ID: 27021205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of the oral gonadotropin-releasing hormone-antagonist elagolix for the management of endometriosis-associated pain.
    Taylor HS; Dun EC; Chwalisz K
    Pain Manag; 2019 Sep; 9(5):497-515. PubMed ID: 31434540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of elagolix in the treatment of endometriosis.
    Perricos A; Wenzl R
    Expert Opin Pharmacother; 2017 Sep; 18(13):1391-1397. PubMed ID: 28737050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Elagolix in Gynaecology.
    Taylor HS
    J Obstet Gynaecol Can; 2018 Jul; 40(7):931-934. PubMed ID: 29921430
    [No Abstract]   [Full Text] [Related]  

  • 8. Elagolix (Orilissa)--an oral GnRH antagonist for endometriosis pain.
    Med Lett Drugs Ther; 2018 Sep; 60(1556):158-160. PubMed ID: 30383729
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Conundrum: A 33-Year-Old With Pain Post-Orgasm and a History of Endometriosis.
    Yong PJ
    J Obstet Gynaecol Can; 2020 May; 42(5):625-628. PubMed ID: 32414477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.
    Alessandro P; Luigi N; Felice S; Maria PA; Benedetto MG; Stefano A
    Arch Gynecol Obstet; 2017 Apr; 295(4):827-832. PubMed ID: 28255765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elagolix for endometriosis: all that glitters is not gold.
    Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
    Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteinizing hormone-releasing hormone antagonists.
    Mezo G; Manea M
    Expert Opin Ther Pat; 2009 Dec; 19(12):1771-85. PubMed ID: 19939192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis.
    Stodtmann S; Nader A; Polepally AR; Suleiman AA; Winzenborg I; Noertersheuser P; Ng J; Mostafa NM; Shebley M
    Clin Transl Sci; 2021 Jul; 14(4):1611-1619. PubMed ID: 33963686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid regression of endometriosis by a new gonadotropin-releasing hormone antagonist in rats with surgically induced disease.
    Sharpe KL; Bertero MC; Vernon MW
    Prog Clin Biol Res; 1990; 323():449-58. PubMed ID: 2406755
    [No Abstract]   [Full Text] [Related]  

  • 16. Elagolix (Orilissa) for Endometriosis Pain.
    Ford B
    Am Fam Physician; 2019 Oct; 100(8):502-504. PubMed ID: 31613570
    [No Abstract]   [Full Text] [Related]  

  • 17. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
    Barra F; Scala C; Ferrero S
    Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.
    Miller JD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1483-8. PubMed ID: 10871469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis.
    Shebley M; Polepally AR; Nader A; Ng JW; Winzenborg I; Klein CE; Noertersheuser P; Gibbs MA; Mostafa NM
    Clin Pharmacokinet; 2020 Mar; 59(3):297-309. PubMed ID: 31749075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elagolix to medically treat a uterine adenomyoma: A case report.
    Kavoussi SK; Esqueda AS; Jukes LM
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():266-267. PubMed ID: 32088070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.